timing of surgery

OTHER2 trials

Sponsors

All India Institute of Medical Sciences, European Organisation for Research and Treatment of Cancer - EORTC

Conditions

Kidney CancerOvarian Carcinoma

Phase 3

Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study

All India Institute of Medical SciencesOvarian Carcinoma

Start: 2001-11-30End: 2009-06-30Target: 180Updated: 2008-07-15

Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer

European Organisation for Research and Treatment of Cancer - EORTCKidney Cancer

Start: 2010-04-30End: 2017-05-31Updated: 2017-02-08

Related Papers

Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma

CA A Cancer Journal for Clinicians2024-04-033 citations

Differences in the exposure to sunitinib in the immediate and deferred cytoreductive nephrectomy (CN) arms of the randomized controlled trial SURTIME.

Journal of Clinical Oncology2020-02-19

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

JAMA Oncology2018-12-13467 citations